Liminatus Pharma Announces Nasdaq Delisting Notification

Peyto Exploration & Development Corp. Announces Voting Results From Annual General Meeting of Shareholders

Robbins LLP Encourages STLA Investors to Contact the Firm for Information About the Class Action Against Stellantis N.V.

Robbins LLP Reminds UHG Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About...

11 Greenberg Traurig Lawyers Recognized in 2026 Lawdragon 100 Leading Immigration Lawyers Guide

TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study

Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026

CALX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Calix, Inc.

CTEV SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.

YSS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.

Z INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Zillow Group, Inc.

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

PHR SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Phreesia, Inc. Investors - Contact Kirby McInerney LLP by July 13, 2026

Rocket Lab Awarded $90M Contract to Build GEO Satellites Hosting Space Domain Awareness Payload for U.S. Space Force

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

Mason Street Wealth Management Introduces Vision-First Retirement Planning Approach to Help Clients Build Financial Confidence

Dionisio Gutiérrez Receives 2026 Beacon Award for His Leadership in Defense of Democracy

2026 ASCO Abstract Highlights | Innovent Announces Preliminary PoC data of IBI363 (PD-1/IL-2α-bias bispecific fusion protein) in Combination...